Shanghai Leado Pharmatech

Leado Biotech is a specialized Contract Research Organization (CRO) focused on translational medicine and personalized oncology services. The company maintains one of the largest Patient-Derived Xenograft (PDX) model libraries in China, facilitating drug screening, biomarker discovery, and preclinical validation for pharmaceutical developers. Their proprietary Mini-PDX technology, branded as Onco-Vane, provides rapid functional drug sensitivity results within seven days to guide clinical decision-making for cancer patients. By integrating genomic data with functional testing, Leado Biotech supports the development of precision medicine and helps optimize therapeutic strategies for complex malignancies. Headquartered in Shanghai, the company operates multiple R&D and service centers to support both global and domestic biopharmaceutical clients.